600713 logo

NanJing Pharmaceutical Company Limited Stock Price

SHSE:600713 Community·CN¥6.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

600713 Share Price Performance

CN¥4.94
-0.30 (-5.73%)
CN¥4.94
-0.30 (-5.73%)
Price CN¥4.94

600713 Community Narratives

There are no narratives available yet.

Recent 600713 News & Updates

NanJing Pharmaceutical's (SHSE:600713) Earnings Seem To Be Promising

Nov 06
NanJing Pharmaceutical's (SHSE:600713) Earnings Seem To Be Promising

Is NanJing Pharmaceutical (SHSE:600713) Using Too Much Debt?

Oct 28
Is NanJing Pharmaceutical (SHSE:600713) Using Too Much Debt?

NanJing Pharmaceutical Company Limited Key Details

CN¥54.4b

Revenue

CN¥51.1b

Cost of Revenue

CN¥3.3b

Gross Profit

CN¥2.8b

Other Expenses

CN¥550.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 31, 2025
Earnings per share (EPS)
0.42
Gross Margin
6.12%
Net Profit Margin
1.01%
Debt/Equity Ratio
157.5%

NanJing Pharmaceutical Company Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Adequate balance sheet second-rate dividend payer.

2 Risks
1 Reward

About 600713

Founded
1951
Employees
4830
CEO
Liang Zhang
WebsiteView website
www.njyy.com

NanJing Pharmaceutical Company Limited engages in the pharmaceutical wholesale and retail businesses in China. It also operates an e-commerce platform. The company was founded in 1951 and is based in Nanjing, China.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Chinese Market Performance

  • 7 Days: 1.8%
  • 3 Months: 18.4%
  • 1 Year: 24.1%
  • Year to Date: 26.2%
The Industrials sector has led the market, which has gained 1.8%. The market is up 24% over the last 12 months. As for the next few years, earnings are expected to grow by 27% per annum. Market details ›